ATHENA ZECHA: Open Payments
NPI 1720040538 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$108 in 2 payments from 2 companies in 2025. Trend: 2023 $35 · 2024 $123 · 2025 $108
Food & beverage: $108
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $69 |
| Stemline Therapeutics Inc. | 1 | $39 |
Products named: ELZONRIS.
Industry payments across WA — which companies pay providers there.
